Medical device maker Boston Scientific said it swung to a third-quarter loss, as legal fees and restructuring expenses weighed down already-sluggish sales of the company’s implants. The Natick company adjusted its full-year guidance. It now expects adjusted earnings of 63 to 66 cents per share. Its prior forecast was 62 to 68 cents. For the quarter, it lost $725 million, or 52 cents per share, compared with a profit of $142 million, or 9 cents, a year earlier.
Boston Scientific posts loss
| Associated Press October 21, 2012
Read it all, now.
Don't miss any of your favorite stories again. Read the stories that matter to you as much as you want, whenever you want when you subscribe to BostonGlobe.com.
Get full access today for just 99¢